Clinical trial
A Clinical Study Evaluating the Safety and Preliminary Effectiveness of Induced Pluripotent Stem Cell-derived Platelets in Patients With Thrombocytopenia Caused by Allogeneic Hematopoietic Stem Cell Transplantation
NCT07905144 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study Evaluating the Safety and Preliminary Effectiveness of Induced Pluripotent Stem Cell-derived Platelets in Patients With Thrombocytopenia Caused by Allogeneic Hematopoietic Stem Cell Transplantation
- Lead sponsor
- Ruijin Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- December 30, 2026
- Completion date
- December 30, 2027
- Enrollment
- 9 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
Lead sponsor's other trials
Ruijin Hospital, most recent start first.
+673 more trials See the organization page
Similar trials
Same condition (Thrombocytopenia) and phase, most recent start first.
+27 more trials See the condition page